Prerecorded Webinar: The Multiple Facets of Multiple Sclerosis

Pharmacist CEU
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, progressive central nervous system (CNS) disease that leads to irreversible disability. MS affects people of all ages, is commonly diagnosed in early adulthood, and is the leading cause of non-traumatic neurological disability in young adults. An abnormal immune response causes inflammation in MS. As knowledge of the disease has evolved, treatment options and approaches have shifted and improved. Disease modifying therapies (DMTs) modify disease course by reducing relapse rate and disability progression. Differing mechanisms of action, administration avenues, dosing, and DMT safety concerns offer healthcare providers and patients many treatment options. A knowledgeable, informed pharmacy team is prepared to educate and counsel patients about MS management.

Course Objectives

Describe the different treatment approaches for relapsing-remitting multiple sclerosis

Identify mechanisms of action associated with current and emerging disease-modifying therapies

Recall common safety considerations associated with treatments for multiple sclerosis

Discuss counseling opportunities for people with multiple sclerosis

I. Introduction

II. Prevalence of Multiple Sclerosis

III. Pathophysiology of Multiple Sclerosis

A. Presentation
B. Diagnosis

IV. RRMS Treatment

A. Efficacy Measurements
B. Progressive Multifocal Leukoencephalopathy
C. Disease Modifying Therapies (DMTs)
D. Interferons and Glatiramer
E. Sphingosine-1-phosphate Receptor Modulators (S1PRM)
F. Fumarates
G. Teriflunomide
H. Cladribine
I. Monoclonal Antibodies
J. Symptom Management, Supportive Care, and Lifestyle Modifications

V. Front Line Support from the Pharmacy Team

VI. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in developing this activity: Jennifer Salvon, RPh, and Pamela Sardo, PharmD, BS. Pamela Sardo and Jennifer Salvon have no conflicts of interest or financial relationships regarding the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by or any of the individuals involved in the development of this activity.

Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of LLC. LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 5/25/2024
  • Activity Expiration Date: 5/25/2027
  • Activity Type: Knowledge
  • UAN: 0669-0000-24-060-H01-P
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1211790


Jennifer Salvon, RPh



The logo for the Accreditation Council for Pharmacy Education (ACPE)., LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List